Published in Pflugers Arch on October 17, 2016
Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev (2006) 8.26
Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol (1996) 4.25
Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol (2000) 4.19
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A (2000) 4.01
Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat Med (1995) 2.76
Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem (2007) 1.85
Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev (2009) 1.66
Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel. Am J Physiol (1998) 1.63
Role of ion channels and transporters in cell migration. Physiol Rev (2012) 1.52
Functional and molecular identification of intermediate-conductance Ca(2+)-activated K(+) channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol (2004) 1.49
Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol (2004) 1.44
Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? Gut (2011) 1.41
Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax (2006) 1.39
Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol (2011) 1.37
Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: a possible role in T cell proliferation. J Immunol (2003) 1.31
Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis. PLoS One (2012) 1.26
Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene (2009) 1.24
Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochem Pharmacol (1987) 1.22
Calcium gradients underlying cell migration. Curr Opin Cell Biol (2011) 1.19
Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest (1994) 1.18
Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. PLoS One (2010) 1.16
Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol (2003) 1.12
The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke. J Cereb Blood Flow Metab (2011) 1.08
Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol (2011) 1.08
Ion channels and cell volume in regulation of cell proliferation and apoptotic cell death. Contrib Nephrol (2006) 1.04
Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells. J Cell Physiol (2006) 1.04
Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring. J Physiol (2010) 1.00
The role of TMEM16A (ANO1) and TMEM16F (ANO6) in cell migration. Pflugers Arch (2013) 0.98
The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells. PLoS One (2012) 0.98
NS6180, a new K(Ca) 3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease. Br J Pharmacol (2013) 0.96
Regulation of Cellular Identity in Cancer. Dev Cell (2015) 0.96
An intermediate-conductance Ca2+-activated K+ channel is important for secretion in pancreatic duct cells. Am J Physiol Cell Physiol (2012) 0.95
Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells. PLoS One (2013) 0.94
ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC). Pflugers Arch (2014) 0.94
The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. J Biol Chem (2013) 0.93
Serum-activated K and Cl currents underlay U87-MG glioblastoma cell migration. J Cell Physiol (2011) 0.93
Cancer as a channelopathy: ion channels and pumps in tumor development and progression. Front Cell Neurosci (2015) 0.92
TRAM-34 inhibits nonselective cation channels. Pflugers Arch (2007) 0.91
Purinoceptors evoke different electrophysiological responses in pancreatic ducts. P2Y inhibits K(+) conductance, and P2X stimulates cation conductance. J Biol Chem (1999) 0.90
Eicosapentaenoic acid inhibits voltage-gated sodium channels and invasiveness in prostate cancer cells. Br J Pharmacol (2009) 0.89
Molecular mechanisms underlying Ca2+-mediated motility of human pancreatic duct cells. Am J Physiol Cell Physiol (2010) 0.88
Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer. Int J Cancer (2015) 0.87
The distribution of intermediate-conductance, calcium-activated, potassium (IK) channels in epithelial cells. J Anat (2006) 0.85
The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Mol Cancer (2015) 0.84
The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP. J Biol Chem (2014) 0.83
Pattern of Ca2+ increase determines the type of secretory mechanism activated in dog pancreatic duct epithelial cells. J Physiol (2006) 0.83
IK1 channel activity contributes to cisplatin sensitivity of human epidermoid cancer cells. Am J Physiol Cell Physiol (2008) 0.81
K+ channel inhibition accelerates intestinal epithelial cell wound healing. Wound Repair Regen (2004) 0.81
The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway. Carcinogenesis (2014) 0.81
Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells. Cell Biochem Biophys (2015) 0.81
Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade. Leukemia (2014) 0.79
TRAM-34, a putatively selective blocker of intermediate-conductance, calcium-activated potassium channels, inhibits cytochrome P450 activity. PLoS One (2013) 0.78
Effect of clotrimazole on cytosolic Ca(2+) rise and viability in HA59T human hepatoma cells. J Recept Signal Transduct Res (2013) 0.78
Human transient receptor potential (TRP) channel expression profiling in carcinogenesis. Int J Dev Biol (2015) 0.78
Novel effects of clotrimazole on Ca2+ signaling in Madin Darby canine kidney cells. Life Sci (2000) 0.76
Hyperpolarization of the cell membrane of mouse hepatocytes by lactate, pyruvate, and fructose is due to Ca2+-dependent activation of K+ channels and of the Na+/K+-ATPase. Biochim Biophys Acta (1998) 0.76
Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines. PLoS One (2016) 0.76
pH-sensitive K(+) channel TREK-1 is a novel target in pancreatic cancer. Biochim Biophys Acta (2016) 0.76
Immature human dendritic cells enhance their migration through KCa3.1 channel activation. Cell Calcium (2016) 0.76
Determination of clotrimazole in mice plasma by capillary electrophoresis. J Pharm Biomed Anal (2003) 0.75
K+ Channel Inhibition Differentially Regulates Migration of Intestinal Epithelial Cells in Inflamed vs. Non-Inflamed Conditions in a PI3K/Akt-Mediated Manner. PLoS One (2016) 0.75